Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

2.69
-0.5100-15.94%
Post-market: 2.750.0600+2.23%19:48 EDT
Volume:7.51M
Turnover:21.04M
Market Cap:585.62M
PE:-5.91
High:3.21
Open:3.20
Low:2.67
Close:3.20
52wk High:8.21
52wk Low:1.90
Shares:217.70M
Float Shares:180.00M
Volume Ratio:2.59
T/O Rate:4.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4548
EPS(LYR):-0.1500
ROE:-37.75%
ROA:-19.58%
PB:1.94
PE(LYR):-17.93

Loading ...

Press Release: CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.p.h., to the Board of Directors

Dow Jones
·
Jul 27

CytomX Therapeutics doubles authorized common shares to 600 million

Reuters
·
Jun 23

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

CytomX Therapeutics Expands Cancer Therapy Partnership With Regeneron; Shares Rise

MT Newswires Live
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Ollie's Bargain Outlet Holdings, Steel Dynamics

Reuters
·
Jun 03

BUZZ-CytomX rises on expanded Regeneron deal with up to $4 billion in milestones

Reuters
·
Jun 03

CytomX expands Regeneron bispecific cancer therapy collaboration, receives $37 million payment

Reuters
·
Jun 03

CytomX Announces Expansion of Strategic Research Collaboration With Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

THOMSON REUTERS
·
Jun 03

CytomX Therapeutics - Regeneron Secures Option for 6 Additional Targets; Total Milestones up to About $4 Bln

THOMSON REUTERS
·
Jun 03

CytomX Therapeutics - to Receive $37 Mln Target Selection Payment for Two Additional Programs

THOMSON REUTERS
·
Jun 03

CytomX Therapeutics - Eligible for Tiered Global Net Sales Royalties Under Collaboration

THOMSON REUTERS
·
Jun 03

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

TIPRANKS
·
May 23

CytomX Therapeutics publishes 2025 annual report

Reuters
·
May 22

CytomX Therapeutics to Present at Upcoming June Investor Conferences

GlobeNewswire
·
May 21

Wolfe Research Initiates CytomX Therapeutics With Outperform Rating

MT Newswires Live
·
May 19

CytomX Therapeutics initiated with an Outperform at Wolfe Research

TIPRANKS
·
May 19

CytomX names Mamata Gokhale as senior vice president of regulatory affairs

Reuters
·
May 18

CytomX Therapeutics Appoints Mamata Gokhale, Ph.d., Rac, as Senior Vice President of Regulatory Affairs

THOMSON REUTERS
·
May 18

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

GlobeNewswire
·
May 18

CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar

TIPRANKS
·
May 16